Literature DB >> 8102062

Taxol and taxotere--current status and future prospects.

D Bissett1, S B Kaye.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8102062     DOI： 10.1016/0959-8049(93)90062-k

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  4 in total

1.  Characterization of lipid droplets from a Taxus media cell suspension and their potential involvement in trafficking and secretion of paclitaxel.

Authors:  Abdulsamie Hanano; Edgar Perez-Matas; Mouhnad Shaban; Rosa M Cusido; Denis J Murphy
Journal:  Plant Cell Rep       Date:  2022-01-04       Impact factor: 4.570

Review 2.  Hypoxia and drug resistance.

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

Review 3.  Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer.

Authors:  C M Spencer; D Faulds
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

4.  Phase II study of docetaxel in patients with metastatic pancreatic cancer: a Japanese cooperative study. Cooperative Group of Docetaxel for Pancreatic Cancer in Japan.

Authors:  S Okada; Y Sakata; S Matsuno; M Kurihara; Y Sasaki; Y Ohashi; T Taguchi
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.